EVIO, Inc. (OTCQB: SGBYD) this morning said that its cannabis testing division, EVIO Labs, has entered into an agreement with Phytatech CO, LLC to license its brand and cannabis technology in Colorado. Per the agreement, Phytatech will now operate under the EVIO Labs brand. “As we continue our mission to become the industry’s largest cannabis testing company, with operations in California, Oregon, Massachusetts, and Florida, EVIO is honored to now offer its accredited testing services to Colorado,” EVIO chief executive officer William Waldrop stated in the news release.
To view the full press release, visit: http://cnw.fm/UgRy3
About EVIO
EVIO, Inc. is a life science company that provides accredited analytical testing services and scientific research to the regulated cannabis industry. The company’s EVIO Labs division provides state-mandated ancillary services that don’t directly support the supply chain, but are in place to ensure the safety and quality of the nation’s cannabis supply. Learn more at www.eviolabs.com.
More from CannabisNewsBreaks
About CBDWire
CBDWire (CBDW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CBDNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CBDW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CBDW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CBDW brings its clients unparalleled visibility, recognition and brand awareness. CBDW is where news, content and information converge.
For more information please visit https://www.cbdwire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
CBDWire (CBDW)
Denver, Colorado
cbdwire.com
303.498.7722 Office
[email protected]
